Overview of CV Receptors and Drug Classes Flashcards

1
Q

all preganglionic neurons?

A

cholinergic

-ACh release to nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

parasympathetic postganglionic?

A

cholinergic

-ACh release mAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

somatic muscle neuron?

A

ACh release to nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sympathetic postganglionic neuron?

A

NE release to alpha/beta receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sympathetic postganglionic to renal?

A

dopamine release to D1 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

release at adrenal medulla?

A

ACh release to nAChR

- stimulates release of Epi and NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

release at sweat glands?

A

ACh release to nAChR preganglionic

ACh release to mAChR postganglionic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

do we have drugs at the nAChR?

A

yes, but not very often used clinically
-because we would have such widespread affect

-ex/ nerve gas, insecticide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

adrenergic receptors?

A

alpha and beta

-GPCRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

muscarine on heart?

A

M2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

muscarinic receptor?

A

GPCR

-activation causes contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

atropine

A

muscarinic cholinergic agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what controls blood vessels?

A

sympathetics only

***may still have the receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

catecholamines?

A
E
NE
isoproterenol
dopamine
dobutamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dobutamine

A

beta1 selective agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

alpha 1 effects?

A

vasoconstriction

-in all vascular beds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

phenylephrine?

A

alpha-adrenergic agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

albuterol?

A

beta-2 selective agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

beta 1 effects?

A

positive ionotropic and chronotropic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

beta 2 effects?

A

relaxation of bronchioles
relaxation of vascular smooth muscle
-skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

epinephrine?

A

sympathomimetic

  • more activity at beta-2 than alpha-1
  • low dose = beta-2 effects
  • drop BP
  • high dose = increases BP
22
Q

bronchial asthma?

A

albuterol

-beta-2 selective agonist

23
Q

norepinephrine?

A

agonist at alpha 1, alpha 2, beta 1
weak beta 2 effects***

positive ionotropic and chronotropic effect
-reflex bradycardia occurs
NET: positive ionotropic and negative chronotropic

increases BP (alpha 1 vasoconstriction)

24
Q

isoproterenol

A

beta-selective agonist

  • beta 1, 2, and 3
  • no affect on alpha receptors

increased HR and contractile force
vasodilation of blood vessels
relaxes bronchial smooth muscle

25
dopamine
agonist at D1 | -increase blood flow to renal arterioles (kidneys)
26
NE
alpha 1 and 2 beta 1 no beta 2 AGONIST
27
Epi
alpha 1, 2 beta 1, 2 AGONIST
28
Isoproterenol
beta1, 2 no alpha AGONIST
29
dopamine
D1 partial beta 1 weak alpha 1 AGONIST
30
bethanechol
muscarinic cholinergic agonist
31
propranolol
non-selective beta1,2 antagonist
32
phenylephrine?
``` alpha-1 selective agonist -vasoconstriction reflex bradycardia (that can be blocked by atropine) ```
33
albuterol?
proventil, ventolin selective beta-2 agonist used for bronchial asthma
34
phentolamine?
competitive adrenergic blocker decrease in BP - block alpha 1 - reflex tachycardia from vasodilation
35
NE effects at low dose?
vasoconstriction - increase (alpha1) -increase in BP - systolic, diastolic, and MAP -decrease in heart rate - baroreceptor reflex SLOW, FORCEFUL HEARTBEAT
36
Epi effects at low dose?
vasodilation (beta2) -drop in diastolic, increased systolic, no change MAP -increased heart rate (beta1)
37
Isoproterenol effects at low dose?
beta2 vasodilation - drops diastolic and MAP, increase systolic - increased heart rate (reflex and beta1)
38
beta2, alpha1 and Epi?
higher affinity for beta2 at low doses | higher affinity for alpha1 at high doses
39
bethanechol
muscarinic agonist | -messes up your GI and other things
40
prazosin
selective postsynaptic alpha1 blocker
41
propanolol
beta1 beta2 antagonist - decreased HR and CO - slow AV conduction, increased PR interval - decreases rate of depolarization of pacemakers blocks beta2 vasodilation -slow decrease TPR blocks bronchodilation -maybe bronchospasm blocks lipolysis and glycogenolysis -no good for diabetics
42
clinical use of propanolol?
angina pectoris HTN arrhythmias
43
atenolol?
beta-1 selective antagonist
44
acetylcholine?
``` short acting (broken down quickly) -not very useful clinically ```
45
bethanechol?
cholinergic agonist that is muscarinic receptor selective -not broken down by acetylcholinesterase
46
muscarinic effects on cardio?
SA - negative chronotropy AV - negative dromotropy atrial - negative inotropy
47
atropine?
mucarinic antagonist reversal of reflex bradycardia causes tachycardia bronchodilation and relaxation
48
ipratropium?
muscarinic antagonist -permanently charged - poorly absorbed across membrane used for asthma and COPD
49
selective vs. nonselective alpha blockers?
nonselective will cause tachycardia -because blocks alpha1 and alpha2 selective won't affect alpha2, therefore you can inhibit the NE release presynaptically phentolamine - nonselective prazosin - selective
50
contraindications to beta-blockers (propanolol)?
asthma and COPD | diabetics (hypoglycemia)
51
bronchospasm relief in COPD?
albuterol ipratropium bromide COMBIVENT
52
metoprolol?
in patients with CHF because it has been shown to decreases mortality in CHF patient